Few direct matches — filled in with the latest updates.
Tag: #immunology3 results
GenSci161, a fully humanized bispecific antibody targeting IL-1α and IL-1β, has received FDA approval for clinical trials in the US. The drug is currently being studied for the treatment of hidradenitis suppurativa.
A small study is exploring the use of CAR-T cell therapy, typically used for cancer, to control HIV long-term. This research suggests a potential shift in how we approach chronic viral infections using immune-modulating technologies.
EVA is a cross-species, multimodal foundation model harmonizing transcriptomics and histology for immunology. It shows scaling laws and SOTA on 39 tasks from discovery to clinical trials. Open version released for transcriptomics research.
Google is introducing a button that lets readers mark publishers as preferred sources across Search, Discover, and Google News. The feature could help publishers recover traffic as AI-powered search generates fewer direct clicks to websites.
Runlayer and Rippling have dropped their lawsuits, with no money changing hands. Rippling marked the resolution by releasing a competing product, leaving the dispute as a cautionary example for founders.
KCD Hangzhou has opened its call for papers, inviting the community to discuss cloud native technologies, observability, and large-model inference in the Agent era. The announcement targets practitioners interested in sharing or learning about the infrastructure behind AI agents.
Wired AI argues that Silicon Valley technology leaders do not understand society’s growing frustrations with AI. The article criticizes their public messaging as disconnected from legitimate concerns about AI’s impact.
GitHub provides an update on the August 17 outage and outlines ongoing work to improve platform reliability. The supplied excerpt does not include specific root-cause findings or remediation details.
Anthropic reportedly expects its IPO to match or exceed SpaceX's record $75 billion raise and could file publicly as soon as the end of this month. The company reportedly recorded an almost $42 billion net loss in 2025, about five times the previous year's figure.
Alibaba’s profit plunged after it raised quarterly capital expenditure for AI to nearly $10 billion. The report also examines Meta’s growing role as a Microsoft AI customer and Castelion’s plans to scale hypersonic missile production.